Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Are An Indian Automaker and Two Biotech Stocks Leading Today’s Gainers?

Page 1 of 2
Key bank earnings and economic data have reinvigorated the U.S stock market today. The Consumer Price Index and initial jobless claims data were better than expected, paving the way for a rally after two days of losses. Three stocks stood out today, namely Keryx Biopharmaceuticals (NASDAQ:KERX)Transition Therapeutics Inc (USA) (NASDAQ:TTHI) and Tata Motors Limited (ADR) (NYSE:TTM). Let’s take a look at why they are surging and whether the smart money saw it coming.
Wall Street Bull

Wall Street Bull

Indian car maker Tata Motors Limited (ADR) (NYSE:TTM) has made headlines today, as investors expect the new round of models introduced by the company’s luxury division, Jaguar Land Rover, will boost sales. Analysts at Ambit Capital believe the introduction of new models, notably the Jaguar XE and Discovery Sport, will result in sales of more than 500,000 vehicles in the 12 months through March, amid strong demand in Europe and the United States. In September, sales were up by 22% to 10,394 cars, with the introduction of the Jaguar XE as the main catalyst. Could this trigger a comeback for the stock? Shares have been on a strong downtrend so far this year, but have managed to stage a small rally since the start of the month, which has continued today with gains of 7.86%.
Follow Tata Motors Ltd (NYSE:TTM)
Trade (NYSE:TTM) Now!
Ken Fisher is a big fan of Tata Motors Limited (ADR) (NYSE:TTM), holding the largest stake among the funds we follow. In its latest 13F filing, Fisher Asset Management reported ownership of 8.17 million shares, up by 18% between April 1 and June 30. Cliff Asness is also optimistic about the prospects of the Indian car maker, lifting his position to 4.36 million shares. In gerenal, however, Tata Motors is not very popular among the hedge funds we track, as their combined positions account for just 3.3% of the company’s common stock. During the second quarter, the number of funds invested in the car maker fell to 20 from 24, while the value of their holdings fell by 19% to $580 million.
Why do we pay attention to hedge fund sentiment? Most investors ignore hedge funds’ moves because as a group their average net returns trailed the market since 2008 by a large margin. Unfortunately, most investors don’t realize that hedge funds are hedged and they also charge an arm and a leg, so they are likely to underperform the market in a bull market. We ignore their short positions and by imitating hedge funds’ stock picks independently, we don’t have to pay them a dime. Our research has shown that hedge funds’ long stock picks generate strong risk-adjusted returns. For instance the 15 most popular small-cap stocks outperformed the S&P 500 Index by an average of 95 basis points per month in our back-tests spanning the 1999-2012 period. We have been tracking the performance of these stocks in real-time since the end of August 2012. After all, things change and we need to verify that back-test results aren’t just a statistical fluke. We weren’t proven wrong. These 15 stocks managed to return 102% over the last 37 months and outperformed the S&P 500 Index by 53 percentage points (see the details here).
On the next page we will discuss the two biotech stocks that have gotten investors excited today.
Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!